Join the Breakthrough Pain group to help and get support from people like you.
Breakthrough Pain News
Related terms: Pain, breakthrough
Four SNPs Linked to Chronic Complex Regional Pain Syndrome Type 1
FRIDAY, Oct. 13, 2023 – Four single nucleotide polymorphisms (SNPs) in four genes are associated with chronic complex regional pain syndrome type 1 (CRPS-1), according to a study published online...
Cannabis Use Relatively Common Among Midlife Women
WEDNESDAY, Sept. 27, 2023 – Current and lifetime medical and recreational cannabis use is relatively common among midlife women, according to a study presented at the annual meeting of the North...
Psychotherapy May Help Ease Fibromyalgia Pain
MONDAY, Sept. 25, 2023 – "Talk therapy" may help people with fibromyalgia manage their chronic pain – and alter the brain's pain-processing circuitry along the way, a new study shows. Researchers...
Cognitive-Behavioral Therapy Helps Relieve Fibromyalgia Pain
FRIDAY, Sept. 22, 2023 – Cognitive-behavioral therapy (CBT) is superior to a matched education treatment in reducing the interfering effects of pain and other aspects of fibromyalgia, according to a...
Most Patients Seen in Emergency Department for Pain Consume Few Opioids After Discharge
THURSDAY, Sept. 21, 2023 – Opioid prescriptions following emergency department discharge should be adapted to specific acute pain conditions, according to a study presented at the annual European...
Medical Marijuana Can Safely Control Cancer Patients' Pain: Study
WEDNESDAY, May 3, 2023 – Medical marijuana can safely reduce cancer pain, and is apparently so effective that patients wind up taking lower amounts of opioids and other pain meds, a new study...
FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
READING, England and BEDMINSTER, N.J., June 30, 2011 /PRNewswire/ – Archimedes Pharma Ltd., and its subsidiary, Archimedes Pharma U.S. Inc., today announced that the U.S. Food and Drug...
FDA Approval for Abstral (Fentanyl) Sublingual Tablets
Uppsala, January 10, 2011 - Orexo AB announces today that its partner ProStrakan Group plc has received approval from the US Food and Drug Administration (FDA) for Abstral. Abstral is licensed for...
Ask a question
To post your own question to this support group, sign in or create an account.